Potential revival of cholinesterase inhibitors as drugs in veterinary medicine

The cholinergic system is involved in the regulation of all organ systems and has acetylcholine (ACh) as almost its only neurotransmitter. Any substance is called cholinergic if it can alter the action of acetylcholine. Cholinesterases (ChEs) are enzymes that enable the hydrolysis of acetylcholine a...

Full description

Bibliographic Details
Main Authors: Neža Žnidaršič, Malan Štrbenc, Neža Grgurevič, Tomaž Snoj
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Veterinary Science
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fvets.2023.1125618/full
_version_ 1811161186034515968
author Neža Žnidaršič
Malan Štrbenc
Neža Grgurevič
Tomaž Snoj
author_facet Neža Žnidaršič
Malan Štrbenc
Neža Grgurevič
Tomaž Snoj
author_sort Neža Žnidaršič
collection DOAJ
description The cholinergic system is involved in the regulation of all organ systems and has acetylcholine (ACh) as almost its only neurotransmitter. Any substance is called cholinergic if it can alter the action of acetylcholine. Cholinesterases (ChEs) are enzymes that enable the hydrolysis of acetylcholine and in this way ensure homeostasis in cholinergic synapses. Cholinesterase inhibitors (ChEi) are a group of indirect-acting cholinergic agonists that influence the activity of the cholinergic system. Several compounds that can inhibit cholinesterases are of importance to veterinary medicine from pharmacological and toxicological perspective. The frequency of their use in veterinary medicine has fluctuated over the years and is now reduced to a minimum. They are mainly used in agriculture as pesticides, and some are rarely used as parasiticides for companion animals and livestock. In recent years, interest in the use of new cholinesterase inhibitors has increased since canine cognitive dysfunction (CCD) became a recognized and extensively studied disease. Similar to Alzheimer's disease (AD) in humans, CCD can be treated with cholinesterase inhibitors that cross the blood–brain barrier. In this review, the mammalian cholinergic system and the drugs that interact with cholinesterases are introduced. Cholinesterase inhibitors that can be used for the treatment of CCD are described in detail.
first_indexed 2024-04-10T06:11:25Z
format Article
id doaj.art-17c0eda89b8649c48b0374960740e8e9
institution Directory Open Access Journal
issn 2297-1769
language English
last_indexed 2024-04-10T06:11:25Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Veterinary Science
spelling doaj.art-17c0eda89b8649c48b0374960740e8e92023-03-02T15:01:29ZengFrontiers Media S.A.Frontiers in Veterinary Science2297-17692023-03-011010.3389/fvets.2023.11256181125618Potential revival of cholinesterase inhibitors as drugs in veterinary medicineNeža ŽnidaršičMalan ŠtrbencNeža GrgurevičTomaž SnojThe cholinergic system is involved in the regulation of all organ systems and has acetylcholine (ACh) as almost its only neurotransmitter. Any substance is called cholinergic if it can alter the action of acetylcholine. Cholinesterases (ChEs) are enzymes that enable the hydrolysis of acetylcholine and in this way ensure homeostasis in cholinergic synapses. Cholinesterase inhibitors (ChEi) are a group of indirect-acting cholinergic agonists that influence the activity of the cholinergic system. Several compounds that can inhibit cholinesterases are of importance to veterinary medicine from pharmacological and toxicological perspective. The frequency of their use in veterinary medicine has fluctuated over the years and is now reduced to a minimum. They are mainly used in agriculture as pesticides, and some are rarely used as parasiticides for companion animals and livestock. In recent years, interest in the use of new cholinesterase inhibitors has increased since canine cognitive dysfunction (CCD) became a recognized and extensively studied disease. Similar to Alzheimer's disease (AD) in humans, CCD can be treated with cholinesterase inhibitors that cross the blood–brain barrier. In this review, the mammalian cholinergic system and the drugs that interact with cholinesterases are introduced. Cholinesterase inhibitors that can be used for the treatment of CCD are described in detail.https://www.frontiersin.org/articles/10.3389/fvets.2023.1125618/fullcholinergic systemcholinesterase inhibitorsorganophosphatescarbamatescanine cognitive dysfunction
spellingShingle Neža Žnidaršič
Malan Štrbenc
Neža Grgurevič
Tomaž Snoj
Potential revival of cholinesterase inhibitors as drugs in veterinary medicine
Frontiers in Veterinary Science
cholinergic system
cholinesterase inhibitors
organophosphates
carbamates
canine cognitive dysfunction
title Potential revival of cholinesterase inhibitors as drugs in veterinary medicine
title_full Potential revival of cholinesterase inhibitors as drugs in veterinary medicine
title_fullStr Potential revival of cholinesterase inhibitors as drugs in veterinary medicine
title_full_unstemmed Potential revival of cholinesterase inhibitors as drugs in veterinary medicine
title_short Potential revival of cholinesterase inhibitors as drugs in veterinary medicine
title_sort potential revival of cholinesterase inhibitors as drugs in veterinary medicine
topic cholinergic system
cholinesterase inhibitors
organophosphates
carbamates
canine cognitive dysfunction
url https://www.frontiersin.org/articles/10.3389/fvets.2023.1125618/full
work_keys_str_mv AT nezaznidarsic potentialrevivalofcholinesteraseinhibitorsasdrugsinveterinarymedicine
AT malanstrbenc potentialrevivalofcholinesteraseinhibitorsasdrugsinveterinarymedicine
AT nezagrgurevic potentialrevivalofcholinesteraseinhibitorsasdrugsinveterinarymedicine
AT tomazsnoj potentialrevivalofcholinesteraseinhibitorsasdrugsinveterinarymedicine